<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自 News-Medical.Net - 来自世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-GB</language><item><title>光驱动细菌可用于瞄准并杀死癌细胞</title><description>高精度靶向恶性肿瘤对于生物医学研究人员来说是一个挑战。然而，在不久的将来，这种情况可能会发生范式转变，通过使用特殊工程细菌，可以有效地消除恶性细胞。</description><link/> https://www.news-medical.net/news/20230829/Light-driven-bacteria-could-be-used-to-target-and-kill-cancer-cells.aspx<comments> https://www.news-medical.net/news/20230829/Light-driven-bacteria-could-be-used-to-target-and-kill-cancer-cells.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=a3534ff2-8bcb-47f8-b663-29ef0925d46e</guid><pubDate> Tue, 29 Aug 2023 21:35:15 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2016/3/bacteria_-_Sebastian_Kaulitzki_46826fb7971649bfaca04a9b4cef3309-620x480.jpg" width="620"><media:description><![CDATA[Light-driven bacteria could be used to target and kill cancer cells]]></media:description></media:content></item><item><title>现代血液稀释剂可降低出血风险</title><description>与传统药物 Waran 相比，现代血液稀释药物（称为 NOAC）在治疗腿部和肺部血栓时可将严重出血的风险降低高达 45%。</description><link/> https://www.news-medical.net/news/20230829/Modern-blood-thinners-linked-to-reduced-risk-of-bleeding.aspx<comments> https://www.news-medical.net/news/20230829/Modern-blood-thinners-linked-to-reduced-risk-of-bleeding.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=29ed3aff-b7ca-48b5-9ff2-d1bd22afe3b5</guid><pubDate> Tue, 29 Aug 2023 21:29:48 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2019/9/Products_containing_potassium_peas%2c_walnuts%2c_beans%2c_parsley%2c_basil%2c_egg_yolk%2c_d_-_Elena_Hramova_M1_941f61af4e8e4d69a5663bde0faacd7d-620x480.jpg" width="620"><media:description><![CDATA[Modern blood thinners linked to reduced risk of bleeding]]></media:description></media:content></item><item><title>钠尿引导利尿治疗可改善急性心力衰竭的充血缓解</title><description>根据今天在 ESC 2023 年大会热线会议上提出的最新突破性研究，急性心力衰竭患者的实用尿钠引导利尿方法可显着增加 24 小时尿钠排泄，而不影响全因死亡率或心力衰竭再住院率。</description><link/> https://www.news-medical.net/news/20230829/Natriuresis-guided-diuretic-therapy-improves-decongestion-in-acute-heart-failure.aspx<comments> https://www.news-medical.net/news/20230829/Natriuresis-guided-diuretic-therapy-improves-decongestion-in-acute-heart-failure.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=b2fa2608-0582-4e01-9333-b24a03005da9</guid><pubDate> Tue, 29 Aug 2023 15:36:59 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/1/Anatomy_of_Human_Heart.-Liya_Graphics_5ac9d64765b747899bc4a9ef77468432-620x480.jpg" width="620"><media:description><![CDATA[Natriuresis-guided diuretic therapy improves decongestion in acute heart failure]]></media:description></media:content></item><item><title>独家：倡导者称 CMS 研究破坏了加强疗养院人员配置的努力</title><description>拜登政府去年承诺为全国约 15,000 家疗养院制定最低人员配置水平。这是改革该行业议程的核心，政府称该行业充斥着不合格的护理和不遵守联邦质量规则的现象。</description><link/> https://www.news-medical.net/news/20230829/Exclusive-CMS-study-sabotages-efforts-to-bolster-nursing-home-staffing-advocates-say.aspx<comments> https://www.news-medical.net/news/20230829/Exclusive-CMS-study-sabotages-efforts-to-bolster-nursing-home-staffing-advocates-say.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=5c38252b-7a3f-4171-a84c-3bee651da8d6</guid><pubDate> Tue, 29 Aug 2023 15:35:18 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Nursing-620x480.jpg" width="620"><media:description><![CDATA[Exclusive: CMS study sabotages efforts to bolster nursing home staffing, advocates say]]></media:description></media:content></item><item><title> ARAMIS 试验发现阿那白滞素对急性心肌炎没有益处</title><description>对急性心肌炎患者进行的最大规模的随机对照试验发现，阿那白滞素是安全的，但并不能减少并发症。今天在 2023 年 ESC 大会的热线会议上介绍了这项最新的突破性研究。</description><link/> https://www.news-medical.net/news/20230829/ARAMIS-trial-finds-no-benefit-of-anakinra-in-acute-myocarditis.aspx<comments> https://www.news-medical.net/news/20230829/ARAMIS-trial-finds-no-benefit-of-anakinra-in-acute-myocarditis.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=dc5b2edd-ab29-4d13-9858-18af21208185</guid><pubDate> Tue, 29 Aug 2023 15:28:12 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/heart-620x480.jpg" width="620"><media:description><![CDATA[ARAMIS trial finds no benefit of anakinra in acute myocarditis]]></media:description></media:content></item><item><title>延长 P2Y12 抑制剂单药治疗可减少 ACS 患者的出血和缺血事件</title><description>经皮冠状动脉介入治疗 (PCI) 后延长 P2Y12 抑制剂单药治疗超过 12 个月可减少急性冠脉综合征 (ACS) 患者的出血和缺血事件，这些患者具有两种类型事件的高风险。</description><link/> https://www.news-medical.net/news/20230829/Extended-P2Y12-inhibitor-monotherapy-reduces-bleeding-and-ischemic-events-in-ACS-患者.aspx<comments> https://www.news-medical.net/news/20230829/Extended-P2Y12-inhibitor-monotherapy-reduces-bleeding-and-ischemic-events-in-ACS-患者.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=17d98166-192b-4c47-b411-eca9a70d97af</guid><pubDate> Tue, 29 Aug 2023 15:22:26 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/1/Heart_-_CLIPAREA_l_Custom_media_2e30afb66e13426eb5cd994ac2980fd7-620x480.jpg" width="620"><media:description><![CDATA[Extended P2Y12 inhibitor monotherapy reduces bleeding and ischemic events in ACS patients]]></media:description></media:content></item><item><title>初次 PCI 后的抗凝治疗并不能预防 STEMI 患者的不良后果</title><description>根据今日 ESC 2023 年大会热线会议上公布的最新突破性研究，初次经皮冠状动脉介入治疗 (PCI) 后的抗凝治疗并不能预防 ST 段抬高型心肌梗死 (STEMI) 患者的不良后果。</description><link/> https://www.news-medical.net/news/20230829/Anticoagulation-after-primary-PCI-does-not-prevent-adverse-outcomes-in-STEMI-患者.aspx<comments> https://www.news-medical.net/news/20230829/Anticoagulation-after-primary-PCI-does-not-prevent-adverse-outcomes-in-STEMI-患者.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=ddc85f6a-54f8-4314-adf6-95a142645a82</guid><pubDate> Tue, 29 Aug 2023 15:04:28 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2015/3/Diabetes_Mellitus1_4a874c8237104d59ac7810769f8e78a2-620x480.jpg" width="620"><media:description><![CDATA[Anticoagulation after primary PCI does not prevent adverse outcomes in STEMI patients]]></media:description></media:content></item><item><title>急性失代偿性心力衰竭早期开始使用达格列净并不能提高利尿效率</title><description>根据 2017 年发表的最新研究，与结构化常规护理相比，早期开始使用钠葡萄糖协同转运蛋白 2 (SGLT2) 抑制剂达格列净并未导致住院急性失代偿性心力衰竭 (ADHF) 患者的利尿效率有统计学上的显着改善。今天在 2023 年 ESC 大会上举行热线会议。</description><link/> https://www.news-medical.net/news/20230829/Early-initiation-of-dapagliflozin-in-acute-decompensated-heart-failure-does-not-improve-diuretic-efficiency.aspx<comments> https://www.news-medical.net/news/20230829/Early-initiation-of-dapagliflozin-in-acute-decompensated-heart-failure-does-not-improve-diuretic-efficiency.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=55b2496a-5a9b-43cf-bcbb-d6cdc80d514f</guid><pubDate> Tue, 29 Aug 2023 14:54:25 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/4/Anatomically_correct_3d_model_of_human_heart-u3d_2cbbdab779c84457877be90c0f055b76-620x480.jpg" width="620"><media:description><![CDATA[Early initiation of dapagliflozin in acute decompensated heart failure does not improve diuretic efficiency]]></media:description></media:content></item><item><title>试验发现，对于窦房结功能障碍患者，最小化心房起搏没有任何益处</title><description>今天在 ESC 2023 年大会热线会议上发表的最新研究表明，最小化心房起搏并不能预防窦房结功能障碍患者的房颤。</description><link/> https://www.news-medical.net/news/20230829/Trial-finds-no-benefit-of-minimizing-atrial-pacing-in-病人-with-sinus-node-dysfunction.aspx<comments> https://www.news-medical.net/news/20230829/Trial-finds-no-benefit-of-minimizing-atrial-pacing-in-病人-with-sinus-node-dysfunction.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=20360c28-a821-4ada-8c5a-00a0df4a9d43</guid><pubDate> Tue, 29 Aug 2023 14:46:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Pacemaker-620x480.jpg" width="620"><media:description><![CDATA[Trial finds no benefit of minimizing atrial pacing in patients with sinus node dysfunction]]></media:description></media:content></item><item><title> SGLT2 抑制剂不会降低住院 COVID-19 患者的 28 天死亡率</title><description>根据今天热线会议上公布的最新研究，与常规治疗或安慰剂相比，钠葡萄糖协同转运蛋白 2 (SGLT2) 抑制剂不会降低住院 COVID-19 患者的 28 天全因死亡率2023 年 ESC 大会。</description><link/> https://www.news-medical.net/news/20230829/SGLT2-inhibitors-do-not-reduce-28-day-mortality-in-hospitalized-COVID-19-病人.aspx<comments> https://www.news-medical.net/news/20230829/SGLT2-inhibitors-do-not-reduce-28-day-mortality-in-hospitalized-COVID-19-病人.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=71781fa1-0677-4a4b-a611-2aa3bb17cbb4</guid><pubDate> Tue, 29 Aug 2023 14:39:56 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Thrombosis-620x480.jpg" width="620"><media:description><![CDATA[SGLT2 inhibitors do not reduce 28-day mortality in hospitalized COVID-19 patients]]></media:description></media:content></item></channel></rss>